Clinical Trials Browser

Medroxyprogesterone Acetate × 30 days × Clear all

NCT07319429 2026-03-13

FEMUS

Phase 2/3 Recruiting

Endometrial Neoplasms

NCT07462663 2026-03-10

SHAPE-ENDO

Not yet recruiting

GynecologicOther

Endometrial Hyperplasia, Neoplasms, Obesity, Endometrial Neoplasms, Overweight

NCT06979596 2026-03-06

OMAHA-015

Phase 2 Recruiting

Neoplasms